Home › Relapsing-Remitting Multiple Sclerosis › Georgia
Relapsing-Remitting Multiple Sclerosis clinical trials in Georgia
3 studies for Relapsing-Remitting Multiple Sclerosis are looking for participants at sites in Georgia.
Cities in Georgia
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
- Shepherd Center, Atlanta
Recruiting
Ages 22 to 60 · All sexes · Updated Sep 2, 2026 · NCT06796504Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
- Georgia State University Biomechanics Lab, Atlanta
Recruiting
Ages 45 to 89 · All sexes · Updated Jun 17, 2026 · NCT06919900Effects of Ublituximab on Motor Functions in Multiple Sclerosis
- Georgia State University, Atlanta
- Atlanta Neuroscience Institute, Atlanta
RecruitingEarly phase 1
Ages 18 to 55 · All sexes · Updated Feb 9, 2026 · NCT06629428From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.